Creador is banking on MG’s low-cost platform to shake up key markets like North Asia and Europe. The challenge? Scaling globally while keeping MG’s lean and efficient DNA intact. Creador has ...

57 A recent analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT ... to eplerenone or placebo in addition to standard medical therapy. Eplerenone (mean dose, 43 mg daily) produced ...

The company markets products under the brand name Ahngook. Ahn-gook Pharm is headquartered in Seoul, South Korea. For a complete picture of Amlodipine + indapamide + valsartan’s drug-specific PTSR and ...

OBJECTIVE: To examine in patients treated with a regimen including single-pill combinations (SPCs) of amlodipine/valsartan (1 ... reductions were 9.8 (10.3) mm Hg, with higher reductions among ...